Mirna Therapeutics (United States)
- Research works
- 66 ▼ 64% vs 2013–17
- Citations
- 6.5k 99.3 per fractional work
- Top-10% rate
- 21.1% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Mirna Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 20.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 20.3×
- Immunology and Microbiology 5.3×
- Biochemistry, Genetics and Molecular Biology 4.2×
- Neuroscience 2.8×
- Medicine 2.2×
- Chemistry 1.3×
- Materials Science 1.2×
- Health Professions 0.7×
- Arts and Humanities 0.7×
- Environmental Science 0.5×
- Earth and Planetary Sciences 0.4×
- Agricultural and Biological Sciences 0.4×
- Social Sciences 0.2×
- Engineering 0.1×
- Computer Science 0.0×
Who are the top researchers at Mirna Therapeutics (United States)?
Ranked on the composite score, Andreas G. Bader lead among researchers whose main affiliation is Mirna Therapeutics (United States).
- 1 Andreas G. Bader United States · #262,275 worldwide 203 citations · 24 works
Which keywords describe research at Mirna Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Biogenesis, Regulation, Biomarkers, Gene Expression, Metastasis, Therapeutics and MicroRNA.
- Ribosome
- PARP Inhibitors
- Homologous Recombination
- Therapeutic Targets
- Long Noncoding RNAs
- Innate Immunity
- Drug Delivery
- Immune Response
- Epigenetic Regulation
- Self-Assembly
- Circular RNAs
- RNA methylation
- Cancer Therapy
- Cancer Progression
- siRNA Delivery
- Gene Therapy
- MicroRNA
- Metastasis
- Biomarkers
- Biogenesis
- Cancer
- Regulation
- Gene Expression
- Therapeutics
- Targeting
- RNA Interference
- Translation
- Cellular Functions
- Nanoparticles
- m6A-seq
- MicroRNA Sponges
- Biosensors
- DNA nanotechnology
- aptamers
- Vaccine
- Cell Death
- RNA Regulation
- BRCA Mutation
- Immunity
- RNA Structure
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer16▲ 17×13 topics
- Biogenesis15▲ 204×3 topics
- Regulation15▲ 36×4 topics
- Biomarkers13▲ 31×4 topics
- Gene Expression12▲ 31×4 topics
- Metastasis12▲ 56×5 topics
- Therapeutics12▲ 125×2 topics
- MicroRNA12▲ 168×1 topic
- Targeting12▲ 294×1 topic
- Gene Therapy6▲ 37×4 topics
- RNA Interference6▲ 74×1 topic
- siRNA Delivery6▲ 111×1 topic
- Translation5▲ 34×2 topics
- Cancer Progression4▲ 26×4 topics
- Cellular Functions4▲ 75×2 topics
- Cancer Therapy4▲ 8.6×10 topics
- Nanoparticles3▲ 3.9×7 topics
- RNA methylation3▲ 61×1 topic
- m6A-seq3▲ 61×1 topic
- Circular RNAs3▲ 171×1 topic
- MicroRNA Sponges3▲ 171×1 topic
- Self-Assembly3▲ 10×2 topics
- Biosensors2▲ 5.7×3 topics
- Epigenetic Regulation2▲ 16×2 topics
- DNA nanotechnology2▲ 31×1 topic
- Immune Response2▲ 5.3×10 topics
- aptamers2▲ 31×1 topic
- Drug Delivery2▲ 6.1×6 topics
- Vaccine2▲ 7.0×6 topics
- Innate Immunity2▲ 7.8×5 topics
- Cell Death2▲ 12×2 topics
- Long Noncoding RNAs2▲ 39×1 topic
- RNA Regulation2▲ 22×1 topic
- Therapeutic Targets2▲ 10×5 topics
- BRCA Mutation2▲ 134×1 topic
- Homologous Recombination2▲ 35×2 topics
- Immunity2▲ 6.6×3 topics
- PARP Inhibitors2▲ 134×1 topic
- RNA Structure2▲ 23×1 topic
- Ribosome2▲ 23×1 topic
Which research topics does Mirna Therapeutics (United States) publish most on?
By volume in 2022–2025: PARP inhibition in cancer therapy, Advancements in Transdermal Drug Delivery, Cancer Treatment and Pharmacology and Advanced Drug Delivery Systems.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 PARP inhibition in cancer therapy Oncology 2 works
- 2 Advancements in Transdermal Drug Delivery Pharmaceutical Science 1 works
- 3 Cancer Treatment and Pharmacology Oncology 0 works
- 4 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Immunotherapy and Immune Responses Immunology 0 works
- 7 Virus-based gene therapy research Genetics 0 works
- 8 Education, Law, and Society Political Science and International Relations 0 works
- 9 Diverse Music Education Insights Music 0 works
- 10 Facial Nerve Paralysis Treatment and Research Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Mirna Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 64% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Austin
- The University of Texas at Austin
- Perfect Harmony Health
- Oracle (United States)
- Dynamic Systems (United States)
- The University of Texas System
- Office of the Attorney General
- Silicon Labs (United States)
- Texas Department of Transportation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.